118 related articles for article (PubMed ID: 6977529)
1. The activity of Sch 29482 against type b Haemophilus influenzae lacking or possessing detectable beta-lactamase activity.
Wong K; Roberts MC; Smith AL
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():163-70. PubMed ID: 6977529
[No Abstract] [Full Text] [Related]
2. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
Doern GV; Jorgensen JH; Thornsberry C; Preston DA
Diagn Microbiol Infect Dis; 1986 Feb; 4(2):95-107. PubMed ID: 3485505
[TBL] [Abstract][Full Text] [Related]
3. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
Bergeron MG; Claveau S; Simard P
Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Hemophilus type B systemic isolates for beta-lactamase and non-beta-lactamase mediated ampicillin resistance and for susceptibility to other antimicrobial agents.
Woolfrey BF; Lally RT; Ederer MN
Am J Clin Pathol; 1987 Sep; 88(3):361-5. PubMed ID: 3498359
[TBL] [Abstract][Full Text] [Related]
5. Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae.
Jorgensen JH; Alexander GA
Antimicrob Agents Chemother; 1978 Feb; 13(2):342-3. PubMed ID: 306221
[TBL] [Abstract][Full Text] [Related]
6. Multiply resistant Haemophilus influenzae type b causing meningitis.
Amarnath SK; Kanungo R; Rao RS; Srinivasan S
Indian J Med Res; 1992 Jul; 95():187-9. PubMed ID: 1398808
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)].
Braveny I
Infection; 1979; 7 Suppl 6():532-9. PubMed ID: 317812
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
[TBL] [Abstract][Full Text] [Related]
9. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Billal DS; Hotomi M; Yamanaka N
Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
[No Abstract] [Full Text] [Related]
10. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase.
Rubin LG; Medeiros AA; Yolken RH; Moxon ER
Lancet; 1981 Nov; 2(8254):1008-10. PubMed ID: 6118476
[TBL] [Abstract][Full Text] [Related]
11. [Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum].
Gaillot O; Simonet M
Pathol Biol (Paris); 1994 May; 42(5):375-7. PubMed ID: 7824299
[TBL] [Abstract][Full Text] [Related]
12. Direct detection by real-time PCR of ftsI gene mutations affecting MICs of β-lactam agents for Haemophilus influenzae isolates from meningitis.
Kishii K; Morozumi M; Chiba N; Ono A; Ubukata K
J Infect Chemother; 2011 Oct; 17(5):671-7. PubMed ID: 21573861
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced.
Hasegawa K; Kobayashi R; Takada E; Ono A; Chiba N; Morozumi M; Iwata S; Sunakawa K; Ubukata K;
J Antimicrob Chemother; 2006 Jun; 57(6):1077-82. PubMed ID: 16617062
[TBL] [Abstract][Full Text] [Related]
14. Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: report of study group.
Philpott-Howard J; Williams JD
Br Med J (Clin Res Ed); 1982 May; 284(6329):1597-9. PubMed ID: 6805619
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Anderson EL; Robinson PA; Tu KK; Adams CR
South Med J; 1985 Jun; 78(6):643-6. PubMed ID: 3873708
[TBL] [Abstract][Full Text] [Related]
16. R-factor mediated beta-lactamase production by Haemophilus influenzae.
Sykes RB; Matthew M; O'Callaghan CH
J Med Microbiol; 1975 Aug; 8(3):437-41. PubMed ID: 1080810
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
Powell M; Williams JD
J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
[TBL] [Abstract][Full Text] [Related]
18. An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b.
Medeiros AA; Levesque R; Jacoby GA
Antimicrob Agents Chemother; 1986 Feb; 29(2):212-5. PubMed ID: 3487284
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.
Picard M; Malouin F
Antimicrob Agents Chemother; 1992 Nov; 36(11):2569-72. PubMed ID: 1489208
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Haemophilus influenzae isolates in Wellington hospital.
Tobias MI; Humble MW
N Z Med J; 1981 Nov; 94(695):334-6. PubMed ID: 6977748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
